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Background: Recovery following stroke depends on cellular plasticity in the perilesional zone (PZ). Doublecortin
(DCX), a protein mainly labeling immature neurons in neurogenic niches is also highly expressed in the vicinity of
focal cortical infarcts. Notably, the number of DCX+ cells positively correlates with the recovery of functional deficits
after stroke though the nature and origin of these cells remains unclear.
Results: In the present study, we aimed to characterize the population of DCX+ cells in the vicinity of ischemic
infarcts in a mouse model in detail. Employing a photothrombosis model, distinct immunohistochemical
techniques, stereology and confocal microscopy, we show that: i) DCX+ cells in the perilesional zone do not
constitute a homogenous population and two cell types, stellate and polar cells can be distinguished according to
their morphology. ii) Stellate cells are mainly located in the lateral and medial vicinity of the insult and express
astrocytic markers. iii) Polar cells are found almost exclusively in the corpus callosum region including in the
preserved deep cortical layers close to the subventricular zone (SVZ). Further, they do not show any colocalisation
of glial markers. Polar morphology and distribution suggest a migration towards the lesion.
Conclusions: In summary, our findings provide evidence that in mice DCX+ cells in the perilesional zone of cortical
infarcts comprise a distinct cell population and the majority of cells are of glial nature.
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The protein doublecortin (DCX) plays a key role in
neuronal migration during development by binding and
stabilizing microtubules as cells migrate towards the
brain surface. Mutations in DCX induce marked migra-
tion defects in humans leading to subcortical band het-
erotopia (SBH, ‘double cortex’ syndrome) in females and
to the more severe lissencephaly (‘smooth brain’ syn-
drome) in males [1,2]. In the adult brain, DCX is still
expressed by immature neurons within the neurogenic
niches, in the dentate gyrus (DG) and in the subventri-
cular zone (SVZ). DCX expression in the DG correlates
with the extent of adult neurogenesis [3] and DCX+
neurons are required for successful acquisition of spatial
learning [4]. Hence, DCX has been widely used as
marker of neuronal precursor cells and neurogenesis.* Correspondence: albrecht.kunze@med.uni-jena.de
1Hans Berger Department of Neurology, Jena University Hospital, Erlanger
Allee 101, D-07747 Jena, Germany
Full list of author information is available at the end of the article
© 2015 Kunze et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Following stroke, DCX was found to be highly
expressed in the perilesional cortex of focal ischemic in-
farcts - beyond the circumscribed neurogenic regions
[5,6]. Notably, the numbers of DCX+ cells in the infarct
vicinity positively correlate with the recovery of func-
tional deficits [7]. In contrast, transgenic conditional ab-
lation of DCX worsens stroke outcome both in the short
and long term on a consistent basis [8,9]. However, it
remains unclear which cells in the perilesional zone
(PZ) express DCX. A few studies provide evidence of
neuroblast migration from the subventricular zone as
well as of the rostral migratory stream towards the le-
sion [5,10,11]. But both the extent and distribution of
DCX expression raise doubts on whether the majority
of DCX+ cells in the infarct vicinity actually migrate
from the SVZ. It is more likely that local residing cells
(e.g. neuronal or glial cells) are stimulated to express
DCX following ischemia.
The goal of the present study was to characterize the
perilesional DCX+ cells in detail with regard to the fol-
lowing three considerations; 1. Do cells show a distinctThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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press different immunhistochemical markers, and if so
which ones? 3. What is the time course of DCX
expression?
Using a focal ischemia model in mice, we demonstrate
the presence of two subpopulations of DCX+ cells in the
perilesional zone. The more abundant DCX+ cell type
reveals a stellate morphology, coexpression of GFAP and
S100B and a similar distribution in the perilesional cor-
tex and the corpus callosum – region (CC-region). The
other DCX+ cell type with a stronger DCX-expression
has fewer processes with polar orientation, is mainly lo-
cated in CC-region, and does not show any expression
of glial markers. Our findings provide evidence that in a
murine model of focal ischemia, the majority of DCX+
cells in the perilesional zone are of glial nature.Results
Morphology of the photothrombotic infarcts
All animals analyzed in the experimental subgroups
showed typical cortical infarcts in the sensorimotor cor-
tex. The cortical infarct affected all cortical layers leavingA
B
Figure 1 Two distinct DCX+ cells can be distinguished in the PZ. Represen
immunohistochemical staining of DCX. (A), Overview of the circumscribed
processes and weaker immunoreactivity, termed DCX+ stellate cells. (C) Th
two processes, note the higher signal intensity of DCX. Scale bars 20 μm.the underlying white matter in the majority of animals
intact. The mediolateral diameter of the lesions was 1.2
± 0.4 mm (n = 10).Identification of two DCX+ cell populations in the
perilesional zone
Our morphological analysis of randomly chosen DCX+
cells (n = 30) in the perilesional zone according to shape
and, in particular according to the number of processes
and their orientation showed two distinct DCX+ cell
subpopulations (Figure 1). One cell type, which we
termed as the DCX+ stellate cell revealed several pro-
cesses radially extending from the soma. The second cell
type had only one or two processes with a strict polar
orientation and we named this cell type, the DCX+ polar
cell. Intensity of DCX-expression was consistently stron-
ger in the DCX+ polar cells. In the next step, we quanti-
fied the two DCX+ cell populations in the PZ. In
particular, we aimed to determine whether both cell
types revealed differences in abundance and spatial dis-
tribution in the infarct vicinity. To this effect we defined
different regions of the PZ as follows: i) the medialC
C
tative images of 40 μm brain sections of C57 mice following
cortical ischemic infarct. (B), Example of DCX+ cell with multiple
e second DCX+ cell type revealed a polar morphology with one or
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region, and iii) the corpus callosum - region (or the CC-
region comprising the corpus callosum and preserved
deep cortical layers). Quantification using a semiauto-
matic stereological system showed that the number of
DCX+ stellate cells were significantly increased by a fac-
tor of 2.54 in the cortex-region of the PZ at day 4 (7286
± 1009 versus 2872 ± 246 cells/mm3, p < 0.01) (Figure 2).
In comparison to the contralateral side, the number of
DCX+ stellate cells remained persistently elevated with a
slight decrease at day 14 and 28 (Day 7: 2.54-fold, day
14: 2.1-fold, day 28: 1.45-fold). No differences were de-
tected between the medial and lateral cortex of the PZ.
Thus, both regions were summarized as the cortex re-
gion of the PZ. Notably, the number of DCX+ stellate
cells in the contralateral side did not change over time.
In the CC-region, we observed an increase of DCX+ stel-
late cells to a similar extent to that in the cortex-regionFigure 2 Quantification of DCX+ stellate cells in the PZ. The number of DCX+
optical-fractionator method. (A), (B), Total numbers of DCX+ stellate cells in th
stellate cells expressing the proliferation marker BrdU at different time points.
both regions following ischemia. Bars represent Mean ± SD. Significant differeof the PZ. Quantification yielded a 2.36-fold elevation of
these cells (8328 ± 1243 vs 3531 ± 234 cells/mm3, p <
0.01) at day 4 (Figure 2). The increase was persistent
with a decline over time at other time points, (Day 7:
2.46-fold, p < 0.05, Day 14: 2.19-fold, p < 0.05, Day 28:
1.60-fold, p < 0.05).
DCX+ polar cells were detected only in the CC-
Region and not observed in the cortex-region even after
repeated scanning of the sections by two different inves-
tigators (Figure 3). DCX+ polar cells were significantly
increased at early time points in the CC-Region com-
pared to the contralateral side (Day 4: 3.8-fold, p < 0.05,
Day 7: 2.54-fold, p < 0.05, Day 14: 1.61-fold, n.s.; Day 28:
1.20-fold, n.s.) (Figure 3).
In summary, DCX+ stellate cells were seen more fre-
quently in the perilesional zone, revealed a similar distri-
bution in both the cortex- and CC-Regions, and were
persistently increased at all time points. In contrast,cells was quantified using semiautomatic stereology system and the
e cortex and CC-Region, respectively. (C), (D), Percentage of DCX +
Notably, the number of DCX+ stellate cells is similarly increased within
nces were indicated as follows: **(p < 0,01), *(p < 0,05).
Figure 3 Quantification of DCX+ polar cells in the PZ. (A) Total numbers of DCX+ polar cells in CC-Region. (B), Percentage of DCX + polar cells
expressing BrdU. (C), Green dots illustrate where polar cells were located in one representative animal. The counting was carried out manually
because of the low numbers of polar cells. Bars represent Mean ± SD. Asterisks indicate significant differences: *(p < 0,05).
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Region and found increased particularly at early time
points in comparison to the contralateral side.
DCX+ stellate cells express glial markers whilst polar cells
do not
Characterisation of the proliferative activity of the two
cell populations by BrdU labeling showed that 17% of
DCX+ stellate cells were BrdU-positive at day 4 in the
cortex- and CC-regions, respectively. At the latter time
points (Day 7 to 28), BrdU-labeling of the DCX-stellate
cells increased, indicating ongoing proliferative activity
after day 4 (Figure 2). Analysis of the proliferation
marker in the DCX+ polar cells revealed a coexpression
of BrdU in 26% of the cells at day 4 (Figure 3). However,
with respect to BrdU labeling, there was no difference to
the contraleral side where 32% of DCX+/BrdU+ cells
were also seen. Compared to controls, numbers of BrdU
+/DCX+ polar cells did not differ significantly at theother time points. Thus, proliferation appeared to be in-
creased especially in the stellate cells of the ipsilateral
hemisphere.
Coexpression studies of other cytochemical markers
yielded the following results: >80% of DCX-stellate cells
coexpressed the glial markers GFAP and S100B whilst
overlap of GFAP and S100 B expression was almost
complete (Figure 4). In contrast, DCX+ polar cells
expressed neither glial proteins nor other markers inves-
tigated in the study (Table 1). Notably, both cell types
revealed no colocalisation with the mature neuronal
marker (NeuN).
We further analyzed the expression pattern of
doublecortin-like (DCL) protein by using specific anti-
bodies provided by Bjarte Havik, Bergen, Norway.
Herein, we found no DCL expression in either DCX+
stellate or in DCX+ polar cells, respectively. The
doublecortin-like (DCL) protein is a splicing variant of
the doublecortin-like kinase (DCLK1) which shares 73%
Figure 4 Coexpression of glial markers by DCX+ stellate cells.
(A-D) Confocal images of single DCX+ stellate cell expressing
S100beta. (E, F) Quantification of GFAP expression by DCX+
stellate cells in the cortex- and CC-region, respectively. Bars represent
Mean ± SD. Significant differences were indicated as follows:
**(p < 0,01), *(p < 0,05). Scale bar 20 μm.
Table 1 Summary of cell markers expressed by DCX+
stellate and polar cells









Iba 1 - -
CD 68 - -
DCLK - -
Immunohistochemical Analysis was performed by confocal microscopy studies
of double or triple labelled sections. The distinct markers are considered to
characterize the following cell types or development stages, BrdU: Thymidine
analogon labelling the proliferating cells. GFAP and S100beta: Astrocytes.
NeuN: Mature neurons. Pax6 and Sox2: Precursor cells. CNPase:
Oligodendrocytes. Iba1 and CD68: Microglia. DCLK: Radial glia and neuronal
precursor cells.
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362 amino acids and also has two DCX domains [12].
DCL is expressed in radial glia-like cells (RGC) duringembryogenesis and neuronal precursor cells in the adult
SVZ [13].
Finally, there have been recent reports stating that dif-
ferent primary AB might yield variable DCX staining
patterns [14]. Herein and in previous experiments, we
primarily used the C18 AB (Santa Cruz Biotechnology)
that is specific against the carboxyl terminus of DCX
protein and revealed reliable intense staining in neuro-
genic regions [7,15] as well as in the cortex [16]. Our
data is in line with the findings of other groups who ana-
lyzed the specificity of C18 AB to DCX [14,17]. How-
ever, to verify our results we performed a series of test
staining with a different DCX antibody (Millipore,
Temecula, CA, USA) which did no differ in its staining
patterns.
Taken together our findings suggest that the majority
of DCX+ stellate cells are of glial origin and that DCX+
polar cells might constitute migrating precursors.
Discussion
DCX has been identified as a microtubule-associated
protein expressed by migrating neuroblasts during a lim-
ited phase of their growth in both developing and adult
mammals [18-20]. DCX plays a crucial role in neuronal
migration by virtue of being involved in microtubule
stabilization [19,21], nuclear translocation [22] and
growth cone dynamics [22-24].
In the adult normal brain, expression of DCX is rare
exterior to the neurogenic areas of the hippocampal for-
mation and subventricular zone. Brown et al. found only
one DCX+ cell in every 20–25 sections of normal adult
rat neocortex [17]. Under pathophysiological conditions,
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altered and DCX+ cells have been observed in distinct
cortical areas [14]. In addition, the DCX+ cell could be
detected within the striatum and cortex following ische-
mia [5,10]. In line with these findings, we showed in a
previous study that a major subset of proliferating BrdU
+ cells coexpressed DCX in the cortical perilesional zone
two weeks after focal infarct [16]. Apparently these cells
did not give rise to neurons since observed no BrdU
+/NeuN+ cells at a latter time point, i.e. six weeks fol-
lowing ischemia. Thus, the nature of DCX+ cells in the
ischemic cortex remains elusive.
Herein, we demonstrate that DCX+ cells in the PZ do
not constitute a homogenous cell population but com-
prise two distinct DCX+ cell types. The more abundant
DCX+ cell type revealed a stellate morphology, was
homogenously distributed in the PZ (Cortex and CC-
Region) and typically expressed glial markers. The other
DCX+ cell type was characterized by polar morphology
with one or two processes. In addition, we detected no
co-labeling with the mature neuronal marker NeuN in
both DCX+ cell types on a constant basis at the different
time points, indicating that DCX+ cells do not differen-
tiate into neurons in the PZ. Taken together, our results
strongly suggest that the majority of DCX+ cells in the
perilesional murine cortex are of glial nature.
DCX is generally considered to be a reliable marker of
immature neurons and neurogenesis [3,5,25,26]. Our re-
sults challenge this assumption, in particular with regard
to the lesioned brain exterior to the neurogenic regions.
Importantly, other authors have also documented DCX
expression in glial cells in previous studies. For example,
in an early report, Nacher et al. described DCX+ cells in
brain parenchyma that showedthe morphology of astro-
cytes [27]. In addition, Verwer et al. (2007) reported
DCX+ astrocytes in the neocortex of post-mortem hu-
man brain tissue. Their data indicate that differentiated
astrocytes in the human neocortex associated with vari-
ous disease backgrounds may contain DCX at levels
around the detection threshold [28]. Further, Bloch et al.
(2011) analyzed the expression pattern of DCX and colo-
calization with distinct cell markers in the cerebral cor-
tex of primates and humans. They found a significant
number of cortically located cells expressing DCX. 26%
of the DCX+ cells coexpressed GFAP. Notably, they con-
firmed their findings by comparing three different
sources of antibodies against DCX [29]. However, the
significance of glial DCX expression still remains specu-
lative. Verwer et al. have suggested a function of DCX in
the glia-to-neuron communication. It is also conceivable
that DCX plays a role in the migration of astrocytes fol-
lowing insults. Alternately, DCX expression might indi-
cate transdifferentiation of mature astrocytes towards a
more plastic “stem cell like” phenotype. Our previousfindings demonstrating that recovery following stroke
correlates with the DCX expression in the PZ [7] suggest
a considerable role of DCX in the reorganization of the
ischemic brain. However, future studies are necessary to
address these questions.
The second DCX+ cell type with a clear polar orienta-
tion was almost exclusively detectable in the CC-Region
close to the subventricular zone. In contrast to the stel-
late cells, DCX+ polar cells did not express any glial pro-
tein or other markers analyzed in the current study
(Table 1). The morphology and location of the DCX+
cells are suggestive of a precursor cell migrating from
the subventricular zone. The DCX+ polar cells also ap-
peared to be much brighter in immunofluorescence
studies indicating a higher level of DCX expression. In
line with previous findings, the stronger DCX signal
might be another hint that the DCX+ polar cells are
possibly migrating precursor cells [30]. However, we
were unable to directly prove the migration of polar cells
from SVZ to the lesion because we did not perform
lineage tracing experiments.
Finally, some authors report a coexpression of NG2
chondroitin sulfate proteoglycan (NG2) by DCX+ cells
in the cortex [31]. NG2 cells comprise the major prolif-
erating cell population in the adult brain. They are
mainly considered to be oligodendrocyte progenitors.
Although, there is an ongoing debate as to whether,
under certain conditions, NG2 cells display features of
multipotent precursor cells and give rise to neurons
[32,33]. Here, we did not perform co-labeling of DCX
and NG2 which might be considered as one limitation
of our study. However, in this study our focus was not
on oligodendrogenesis but rather on the analysis of the
co-expression of other glial markers by DCX-positive
cells.
In summary, our study sheds more light on the DCX+
cell population in the perilesional zone of ischemic infarcts
in mice. It challenges the view that doublecortin is a spe-
cific marker of cells committed to neuronal lineage in par-
ticular outside of the neurogenic regions in the lesioned
brain. Further studies are required to elucidate the func-
tional role of the distinct DCX+ cells following ischemia.Conclusion
Taken together, our study provides evidence that in mice
DCX+ cells in the perilesional zone of focal cortical in-
farcts comprise two distinct cell populations. According
to their morphology and marker expression the majority
of DCX+ cells have a glial nature.Methods
The study was performed on a total number of 32 adult
male C57BL/6 J mice (11 to 15 weeks of age, 20–30 g).
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ordinary cages (5animals/cage). Food and water were
provided ad libitum. All experimental procedures were
approved by the German Animal Care and Use Commit-
tee in accordance with the European Directives.
Induction of photothrombotic infarcts
28 animals received photothrombotic cortical infarcts in
the right sensorimotor forelimb cortex, 4 animals were
sham operated. Infarcts were induced using the method
initially described by Watson [34], adapted for mice by
Schroeter [35] and modified partially. Briefly, animals
were anesthetized using 1.5 − 2.5% isoflurane in a mix-
ture of oxygen/nitrous oxide (20%/60%). A fiber optic
bundle with a 1.8 mm aperture diameter was connected
to a cold light source (KL 1500, Schott, Jena, Germany),
positioned on the skull 1.0 mm anterior to bregma and
1.8 mm lateral to midline, and adjusted to the stereo-
taxic coordinates of the forelimb sensorimotor cortex
(Paxinos, 2001). The light was turned on for 15 min. Three
repetitive injections of 0.1 ml Rose Bengal (10 mg/ml in
0.9% NaCl; Sigma-Aldrich, Taufkirchen, Germany) were
given at an interval of 5 min, starting 5 min before light
onset. After surgery, the animals were returned to their
cages and placed under 12 h light/12 h dark conditions.
Experimental design
All mice received two intraperitoneal injection of 5-
bromo-2-deoxyuridine (BrdU, 50 mg/kg body weight)
daily with a two hour gap over four sequential days after
infarct induction and were allocated to four experimen-
tal groups with different survival times (4, 7, 14 or
28 days, Additional file 1: Figure S1).
Tissue preparation and immunocytochemistry
The animals were deeply anesthetized with diethylether
and perfused through the ascending aorta with 4% para-
formaldehyde in phosphate buffer (0.15 mol/L, pH 7.4).
Brains were removed immediately after perfusion and
postfixed in 4% paraformaldehyde in phosphate buffer
overnight. All samples were then cryoprotected in
phosphate-buffered saline containing 30% sucrose for
24 h and stored at - 75°C for further processing. Sequen-
tial sections were cut using a freezing microtome
(40 lm) and stored at - 20°C until further processing.
Free-floating 40 μm sections were treated with 0.6%
H2O2 in Tris-buffered saline (0.15 M NaCl, 0.1 M
TrisH2O2 in Tris-buffered saline (0.15 M NaCl, 0.1 M
Tris–HCl, pH 7.5) for 30 min to block endogenous per-
oxidase. After washing, the sections were incubated in
2 N HCl at 37°C for 30 min. Sections were rinsed in
boric acid (pH 8.5) and after several rinses in Tris-
buffered saline containing 0.25% Triton X-100 (Tris-
Triton), sections were incubated overnight at 4°C inprimary goat polyclonal or guinea pig polyclonal anti-
Doublecortin (1:200) in TBS-Triton containing 5%
normal donkey serum or 5% goat serum. The next day,
sections were incubated in biotinylated donkey anti goat
or anti guinea pig antisera (1:500, Jackson Immunore-
search, West Grove, PA) for 2 h, rinsed and incubated in
avidin-biotin-peroxidase complex (Vector Laboratories,
Burlingame, CA) for 60 min. Finally, they were reacted
for peroxidase detection in a solution of 3.3-diamino-
benzidine (0.25 mg/mL; Sigma- Aldrich, Munich,
Germany) containing 0.01% H2O2. Sections were thor-
oughly washed, mounted, and coverslipped. For double
or triple immunofluorescence staining, the brains were
treated in the same way as described for immunoperoxi-
dase staining aside from pretreatment with Tris-H2O2.
Sections were then incubated with different primary
antibodies (Additional file 2: Table S1) for 24 hours,
followed by incubation for 48 hours with secondary anti-
bodies labelled with distinct fluorochromes (Additional
file 2: Table S1). Sections were rinsed again, mounted
onto gelatin-coated slides and coverslipped in polyvinyl
alcohol with diazabicyclo-octane (DABCO) as antifading
agent. For double or triple immunofluorescence stain-
ings, we applied the following combinations of primary
antibodies: DCX-BrdU-NeuN, DCX-BrdU-GFAP, DCX-
BrdU-S100B, DCX-Sox2, DCX-Pax6, DCX-CNPase, DCX-
CD68-IbA, DCX-DCLK.
Quantification and statistical analysis
To quantify DCX-labeled cells with a stellate morphology
in the perilesional area, the optical fractionator method as a
semi-automatic stereological system was used. The perile-
sional zone was defined as an approximately 350 μm wide
frame that directly surrounding the infarct (Additional file
1: Figure S1). The following stereological parameters were
used: 80 × 80 μm2 counting frame and a 100 × 180 μm2
sampling grid. Section thicknesses were measured and ap-
propriate guard zones at the top and the bottom of the sec-
tion were defined to avoid over sampling. The boundaries
of the perilesional areas were delineated using a 5× object-
ive and the numbers of the DCX positive cells (peroxidase
method) were counted at a magnification of 63 ×. Positive
cells, which intersected the uppermost focal plane and the
lateral exclusion boundaries of the counting frame were not
counted. BrdU counts were calculated as absolute numbers
per mm3 sectional volume. To quantify the DCX-labelled
polar cells, the perilesional zone was defined in the same
way but the counting was carried out manually because of
the low numbers of polar cells. To phenotype the DCX-
positive cells, coexpression of other cell specific markers
(Table 1) were analyzed by confocal laser scanning micros-
copy (LSM Meta 710; Zeiss, Germany). For each animal,
about 50 DCX-positive stellate cells and all detectable polar
cells were colocalized employing z-stacks. The absolute
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multiplying the absolute number of DCX-positive stellate
cells with the percentage of cell marker of interest. In gen-
eral, every 12th brain section was used for quantification or
phenotyping of DCX-positive cells by confocal laser mi-
croscopy. The intensity of DCX expression was assessed by
visual control by two independent investigators who cate-
gorized the cells as being weak or bright fluorescent.
Statistical analyses were performed using SPSS 19.0 for
Windows. Differences were assessed with the Mann–
Whitney U test. Data are given as mean ± SD unless
otherwise noted. P values < 0.05 were considered statisti-
cally significant.
Additional files
Additional file 1: Figure S1. Illustration of experimental design.
Additional file 2: Table S1. Primary antibodies and secondary
antibodies used for immunohistochemistry.
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